Literature DB >> 10632290

Human papillomavirus testing for primary cervical cancer screening.

J Cuzick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10632290     DOI： 10.1001/jama.283.1.108

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.

Authors:  K W Hart; O M Williams; N Thelwell; A N Fiander; T Brown; L K Borysiewicz; C M Gelder
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Quantitative screening of single copies of human papilloma viral DNA without amplification.

Authors:  Jiangwei Li; Ji-Young Lee; Edward S Yeung
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

Review 3.  What we could do now: molecular pathology of gynaecological cancer.

Authors:  C S Herrington
Journal:  Mol Pathol       Date:  2001-08

Review 4.  Pap test results. Responding to Bethesda system reports.

Authors:  T J Colgan
Journal:  Can Fam Physician       Date:  2001-07       Impact factor: 3.275

5.  Will New Human Papillomavirus Diagnostics Improve Cervical Cancer Control Efforts?

Authors:  Shalini L. Kulasingam; Laura A. Koutsky
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

6.  Factors affecting the detection rate of human papillomavirus.

Authors:  Diane M Harper; Meghan R Longacre; Walter W Noll; Dorothy R Belloni; Bernard F Cole
Journal:  Ann Fam Med       Date:  2003 Nov-Dec       Impact factor: 5.166

7.  Human papillomavirus DNA in plasma of patients with cervical cancer.

Authors:  W Pornthanakasem; K Shotelersuk; W Termrungruanglert; N Voravud; S Niruthisard; A Mutirangura
Journal:  BMC Cancer       Date:  2001-03-05       Impact factor: 4.430

8.  Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing.

Authors:  F Carozzi; G Ronco; M Confortini; D Noferini; C Maddau; S Ciatto; N Segnan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

9.  Influences on uptake of reproductive health services in Nsangi community of Uganda and their implications for cervical cancer screening.

Authors:  Twaha Mutyaba; Elisabeth Faxelid; Florence Mirembe; Elisabete Weiderpass
Journal:  Reprod Health       Date:  2007-06-26       Impact factor: 3.223

10.  Extended duration of the detectable stage by adding HPV test in cervical cancer screening.

Authors:  M E van den Akker-van Marie; M van Ballegooijen; L Rozendaal; C J L M Meijer; J D F Habbema
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.